A novel oxidized low-density lipoprotein-binding protein, Asp-hemolysin, recognizes lysophosphatidylcholine

被引:40
作者
Kudo, Y
Ootani, T
Kumagai, T
Fukuchi, Y
Ebina, K
Yokota, K
机构
[1] Tohoku Pharmaceut Univ, Dept Hyg Chem 1, Aoba Ku, Sendai, Miyagi 9818558, Japan
[2] Japanese Red Cross Sendai Hosp, Taihaku Ku, Sendai, Miyagi 9828501, Japan
[3] Sendai City Hosp, Hyg Res Lab, Japan Railway Co, Aoba Ku, Sendai, Miyagi 9808508, Japan
关键词
Asp-hemolysin; oxidized low-density lipoprotein; lysophosphatidylcholine;
D O I
10.1248/bpb.25.787
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Oxidized low-density lipoprotein (Ox-LDL) plays an important role in the initiation and progression of ath-erosclerosis. Asp-hemolysin, a hemolytic toxin from Aspergillus fumigatus, is a specific, high affinity binding protein for Ox-LDL. We have previously shown that Ox-LDL strongly inhibits the hemolytic activity of Asp-hemolysin, and that the removal of lysophosphatidyleholine (lysoPC) from Ox-LDL abolished the inhibition. In the present study, to clarify the binding mechanism of Asp-hemolysin to Ox-LDL, we investigated the interaction between Asp-hemolysin and lysoPC as a typical lipid moiety of Ox-LDL. Based on western blot analysis, the binding of Asp-hemolysin to LDL, oxidized for different times, depended on the lysoPC content in each Ox-LDL. In addition, the inhibition of lysoPC production in Ox-LDL by phenylmethylsulfonyl fluoride (PMSF) pretreatment of LDL resulted in a marked decrease of Asp-hemolysin binding to PMSF-pretreated Ox-LDL. Furthermore, the binding analysis of Asp-hemolysin to lysoPC using ion-exchange chromatography revealed that Asp-hemolysin directly binds to lysoPC.
引用
收藏
页码:787 / 790
页数:4
相关论文
共 15 条
  • [1] CLONING AND NUCLEOTIDE-SEQUENCE OF CDNA-ENCODING ASP-HEMOLYSIN FROM ASPERGILLUS-FUMIGATUS
    EBINA, K
    SAKAGAMI, H
    YOKOTA, K
    KONDO, H
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1994, 1219 (01): : 148 - 150
  • [2] Fukuchi Y, 1998, FEMS MICROBIOL LETT, V167, P275, DOI 10.1111/j.1574-6968.1998.tb13239.x
  • [3] Fukuchi Y, 1996, BIOL PHARM BULL, V19, P547, DOI 10.1248/bpb.19.547
  • [4] DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM
    HAVEL, RJ
    EDER, HA
    BRAGDON, JH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) : 1345 - 1353
  • [5] Oxidized low-density lipoprotein-binding specificity of Asp-hemolysin from Aspergillus fumigatus
    Kudo, Y
    Fukuchi, Y
    Kumagai, T
    Ebina, K
    Yokota, K
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2001, 1568 (03): : 183 - 188
  • [6] Kudo Y, 1999, BIOL PHARM BULL, V22, P549, DOI 10.1248/bpb.22.549
  • [7] LOWRY OH, 1951, J BIOL CHEM, V193, P265
  • [8] ESSENTIAL ROLE OF PHOSPHOLIPASE-A2 ACTIVITY IN ENDOTHELIAL CELL-INDUCED MODIFICATION OF LOW-DENSITY LIPOPROTEIN
    PARTHASARATHY, S
    STEINBRECHER, UP
    BARNETT, J
    WITZTUM, JL
    STEINBERG, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (09) : 3000 - 3004
  • [9] THE PATHOGENESIS OF ATHEROSCLEROSIS - A PERSPECTIVE FOR THE 1990S
    ROSS, R
    [J]. NATURE, 1993, 362 (6423) : 801 - 809
  • [10] STEINBRECHER UP, 1989, J LIPID RES, V30, P305